Biotek-snakken — Juni 2021
-
der falder den nok 50%
-
****ORPHAZYME: IKKE KENDSKAB TIL EGENTLIGT ÆNDRINGER
-
****ORPHAZYME: HVERKEN I KLINISK ELLER FINANSIELLE FORHOLD
-
Orphazyme ligger over 75 kr efter godkendelse i næste uge.
-
Positiv melding BetgenBio: BGBIO: Presenterer lovende preliminære data fra fase II-studie
9:23
Oslo (TDN Direkt): Bergenbio vil presentere oppdaterte foreløpige overlevelsesdata fra den pågående fase II-studien av bemcentinib (BGBC003) i kombinasjon med lav-dose cytarabin -
Tak Darvin, fin nyhed
- og her er linket https://newsweb.oslobors.no/message/535671 -
Hansa Biopharma brud op?
https://www.proinvestor.com/boards/94162/Hansa-Biopharma-brud-op?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Lige der ønskede jeg min position i ADS'en